A new generation of pharmaceutical research & manufacturing is rising
Pathogen inactivation is
expensive, complex and time consuming.
Pathogen contamination in the biopharma process industry and the targeted inactivation of infectious microbes
may be two completely different problems – but they share a common characteristic.
It is about the neutralization of dangerous targets in liquid solutions.
Today we lack highly flexible solutions to serve both use cases.
The Next Step
Join us in reshaping
the pharmaceutical future
INACTIVATE – created for the future
We are looking for development partners and lead projects to further develop the innovative technology. Book a short call now!